AW
FOLD

Avion Wealth’s Amicus Therapeutics FOLD Stock Holding History

Avion Wealth’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Sell
192
-35
-15% -$502 ﹤0.01% 861
2025
Q4 		$3K Sell
227
-47
-17% -$462 ﹤0.01% 779
2025
Q3 		$2K Buy
274
+51
+23% +$363 ﹤0.01% 853
2025
Q2 		$1K Buy
223
+170
+321% +$1.1K ﹤0.01% 969
2025
Q1 		$0 Buy
+53
New +$490 ﹤0.01% 1140

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Avion Wealth's FOLD Position: Q1 2026 in Review

Avion Wealth reduced its Amicus Therapeutics (FOLD) stake by 15% in Q1 2026, selling an estimated $502 and leaving 192 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #861.

Avion Wealth first reported a position in FOLD in Q1 2025 and has held it in 5 quarters since. The position peaked at $3K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Avion Wealth held 192 shares of Amicus Therapeutics worth $2K as of Q1 2026.
  • Avion Wealth sold 35 Amicus Therapeutics shares in Q1 2026, an estimated $502.
  • Amicus Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #861 holding.
  • Avion Wealth first reported a position in Amicus Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Avion Wealth's Amicus Therapeutics position peaked at $3K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.